A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 9,375 shares of BGNE stock, worth $1.9 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares
9,375
Previous 10,464 10.41%
Holding current value
$1.9 Million
Previous $1.49 Million 41.02%
% of portfolio
4.12%
Previous 2.54%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$143.93 - $224.51 $156,739 - $244,491
-1,089 Reduced 10.41%
9,375 $2.1 Million
Q2 2024

Aug 02, 2024

SELL
$129.52 - $174.32 $906 - $1,220
-7 Reduced 0.07%
10,464 $1.49 Million
Q1 2024

May 08, 2024

BUY
$141.8 - $181.47 $88,766 - $113,600
626 Added 6.36%
10,471 $1.64 Million
Q4 2023

Jan 19, 2024

BUY
$158.67 - $201.58 $898,865 - $1.14 Million
5,665 Added 135.53%
9,845 $1.78 Million
Q3 2023

Nov 01, 2023

SELL
$179.87 - $225.13 $359 - $450
-2 Reduced 0.05%
4,180 $751,000
Q2 2023

Aug 04, 2023

SELL
$178.3 - $266.78 $356 - $533
-2 Reduced 0.05%
4,182 $745,000
Q1 2023

May 05, 2023

BUY
$215.53 - $274.5 $3,232 - $4,117
15 Added 0.36%
4,184 $901,000
Q3 2022

Nov 04, 2022

SELL
$131.8 - $202.24 $13,575 - $20,830
-103 Reduced 2.41%
4,169 $562,000
Q2 2022

Aug 01, 2022

SELL
$121.11 - $216.05 $363 - $648
-3 Reduced 0.07%
4,272 $691,000
Q1 2022

May 05, 2022

SELL
$146.52 - $269.56 $4,688 - $8,625
-32 Reduced 0.74%
4,275 $806,000
Q4 2021

Feb 03, 2022

SELL
$248.56 - $389.34 $248 - $389
-1 Reduced 0.02%
4,307 $1.17 Million
Q3 2021

Nov 04, 2021

SELL
$249.6 - $403.14 $200,928 - $324,527
-805 Reduced 15.74%
4,308 $1.56 Million
Q2 2021

Aug 09, 2021

BUY
$292.75 - $367.01 $292 - $367
1 Added 0.02%
5,113 $1.76 Million
Q1 2021

May 11, 2021

SELL
$260.64 - $382.12 $145,958 - $213,987
-560 Reduced 9.87%
5,112 $1.78 Million
Q4 2020

Jan 27, 2021

BUY
$221.31 - $316.61 $5,532 - $7,915
25 Added 0.44%
5,672 $1.47 Million
Q3 2020

Nov 12, 2020

BUY
$189.18 - $286.44 $18,350 - $27,784
97 Added 1.75%
5,647 $1.62 Million
Q1 2020

May 07, 2020

SELL
$121.84 - $173.19 $12,549 - $17,838
-103 Reduced 1.82%
5,550 $683,000
Q4 2019

Jan 24, 2020

BUY
$115.78 - $208.34 $7,873 - $14,167
68 Added 1.22%
5,653 $937,000
Q3 2019

Oct 29, 2019

BUY
$120.61 - $148.29 $147,144 - $180,913
1,220 Added 27.95%
5,585 $684,000
Q2 2019

Jul 19, 2019

BUY
$113.99 - $146.86 $69,305 - $89,290
608 Added 16.18%
4,365 $541,000
Q4 2018

Jan 23, 2019

BUY
$107.01 - $175.15 $402,036 - $658,038
3,757 New
3,757 $527,000

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $21B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.